April 12 (Reuters) - BB Biotech AG:
* SAID ON THURSDAY CONCLUDES ITS SHARE BUYBACK PROGRAM AND LAUNCHES A NEW BUYBACK PROGRAM
* CONCLUDED THE SHARE BUYBACK PROGRAM IT HAD INITIATED ON APRIL 12, 2016. DURING THIS PERIOD NO REGISTERED SHARES WERE REPURCHASED VIA A SECOND TRADING LINE
* DECIDED TO LAUNCH A NEW SHARE REPURCHASE PROGRAM IMMEDIATELY AFTER THE CONCLUSION OF THIS BUYBACK PROGRAM
* AUTHORIZED TO REPURCHASE UP TO 10% OF ITS SHARES (5 540 000 SHARES) OVER A PERIOD OF 36 MONTHS
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
Our Standards: The Thomson Reuters Trust Principles.